NSE and BSE clear Religare demerger scheme with Finvest

Core Business DivestedStrategic Transactions View source PDF Explain this filing

RELIGARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹271.30

prior close

₹270.00

announcement price

After-mkt

timing

Nifty Microcap 250market-2.0%+0.4% vs market

Investment Company peers, median of 60sector-1.5%-0.1% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.1 pts less than its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-0.4

15m

-0.4

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6-2.0+0.4-1.5-0.1

Next day

+0.7-0.1+0.8-0.6+1.3

-0.5+1.2-1.7+0.0-0.5

-1.2+1.4-2.6+0.3-1.5

-3.4+0.4-3.8-0.4-3.0

-1.0+1.0-2.0-0.6-0.5

-5.3-0.5-4.8-1.3-4.1

15d

-7.4-0.6-6.9-2.3-5.1

-15.2+3.4-18.6-1.2-14.0

-6.0+6.0-12.0-2.7-3.3

-18.7+1.1-19.8-9.3-9.4

UpDownMarket · Nifty Microcap 250Sector · Investment Company peers, median of 60Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Religare Enterprises received no-objection from NSE and no adverse observations from BSE for its demerger scheme with Religare Finvest. The scheme will transfer business from Religare Enterprises to Religare Finvest. With exchange clearance, REL can now file the scheme with NCLT. Shareholder, creditor and other regulatory approvals still needed. Religare Finvest is expected to be listed. Observation letters valid for 6 months from July 7, 2026.

Likely market impact

Positive milestone for the demerger. Exchange clearance allows NCLT filing. Shareholder, creditor and other approvals still pending.